Alzinova AB (ALZ) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.047x

Based on the latest financial reports, Alzinova AB (ALZ) has a cash flow conversion efficiency ratio of 0.047x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr5.78 Million ≈ $621.81K USD) by net assets (Skr121.96 Million ≈ $13.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALZ defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Alzinova AB - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Alzinova AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Alzinova AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alzinova AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
EXCELLENCE S.A. ZY -10 F:8XY	0.086x
Target Healthcare REIT Ltd LSE:THRL	0.033x
Samyang Corp Preference Shares KO:145995	-0.026x
Cambium Bio Ltd AU:CMB	-1.444x
Labrador Gold Corp V:LAB	-0.002x
DarkIris Inc. Class A Ordinary Shares NASDAQ:DKI	N/A
Renoworks Software Inc V:RW	-1.842x
GCP Infrastructure Investments Limited LSE:GCP	0.039x

Annual Cash Flow Conversion Efficiency for Alzinova AB (2014–2025)

The table below shows the annual cash flow conversion efficiency of Alzinova AB from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Alzinova AB stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr121.96 Million ≈ $13.12 Million	Skr-13.03 Million ≈ $-1.40 Million	-0.107x	+34.72%
2024-12-31	Skr123.82 Million ≈ $13.33 Million	Skr-20.27 Million ≈ $-2.18 Million	-0.164x	-22.49%
2023-12-31	Skr113.86 Million ≈ $12.25 Million	Skr-15.21 Million ≈ $-1.64 Million	-0.134x	-36.72%
2022-12-31	Skr105.53 Million ≈ $11.36 Million	Skr-10.31 Million ≈ $-1.11 Million	-0.098x	+11.95%
2021-12-31	Skr88.47 Million ≈ $9.52 Million	Skr-9.82 Million ≈ $-1.06 Million	-0.111x	-70.10%
2020-12-31	Skr96.02 Million ≈ $10.33 Million	Skr-6.27 Million ≈ $-674.29K	-0.065x	+2.98%
2019-12-31	Skr59.11 Million ≈ $6.36 Million	Skr-3.98 Million ≈ $-427.85K	-0.067x	-8.08%
2018-12-31	Skr63.75 Million ≈ $6.86 Million	Skr-3.97 Million ≈ $-426.95K	-0.062x	+14.16%
2017-12-31	Skr29.39 Million ≈ $3.16 Million	Skr-2.13 Million ≈ $-229.31K	-0.072x	+16.33%
2016-12-31	Skr31.90 Million ≈ $3.43 Million	Skr-2.76 Million ≈ $-297.46K	-0.087x	+44.29%
2015-12-31	Skr20.63 Million ≈ $2.22 Million	Skr-3.21 Million ≈ $-345.40K	-0.156x	+66.23%
2014-12-31	Skr1.55 Million ≈ $167.09K	Skr-715.19K ≈ $-76.97K	-0.461x	--

About Alzinova AB

ST:ALZ Sweden Biotechnology

Market Cap

$8.00 Million

Skr74.30 Million SEK

Market Cap Rank

#27570 Global

#612 in Sweden

Share Price

Skr0.48

Change (1 day)

-0.10%

52-Week Range

Skr0.40 - Skr2.03

All Time High

Skr26.90